Literature DB >> 33477783

Role of Tristetraprolin in the Resolution of Inflammation.

Peter Rappl1, Bernhard Brüne1,2,3,4, Tobias Schmid1.   

Abstract

Inflammation is a crucial part of immune responses towards invading pathogens or tissue damage. While inflammatory reactions are aimed at removing the triggering stimulus, it is important that these processes are terminated in a coordinate manner to prevent excessive tissue damage due to the highly reactive inflammatory environment. Initiation of inflammatory responses was proposed to be regulated predominantly at a transcriptional level, whereas post-transcriptional modes of regulation appear to be crucial for resolution of inflammation. The RNA-binding protein tristetraprolin (TTP) interacts with AU-rich elements in the 3' untranslated region of mRNAs, recruits deadenylase complexes and thereby facilitates degradation of its targets. As TTP regulates the mRNA stability of numerous inflammatory mediators, it was put forward as a crucial post-transcriptional regulator of inflammation. Here, we summarize the current understanding of the function of TTP with a specific focus on its role in adding to resolution of inflammation.

Entities:  

Keywords:  AU-rich element; RNA-binding protein; mRNA stability; post-transcriptional regulation

Year:  2021        PMID: 33477783      PMCID: PMC7832405          DOI: 10.3390/biology10010066

Source DB:  PubMed          Journal:  Biology (Basel)        ISSN: 2079-7737


  122 in total

1.  Differential regulation by Toll-like receptor agonists reveals that MCPIP1 is the potent regulator of innate immunity in bacterial and viral infections.

Authors:  E Blazusiak; D Florczyk; J Jura; J Potempa; J Koziel
Journal:  J Innate Immun       Date:  2012-07-06       Impact factor: 7.349

Review 2.  The nuclear factor NF-kappaB pathway in inflammation.

Authors:  Toby Lawrence
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-07       Impact factor: 10.005

3.  Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.

Authors:  Sandra L Clement; Claudia Scheckel; Georg Stoecklin; Jens Lykke-Andersen
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

Review 4.  Macrophage activation by endogenous danger signals.

Authors:  X Zhang; D M Mosser
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

5.  Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells.

Authors:  Zhaoyuan Liu; Yaqi Gu; Svetoslav Chakarov; Camille Bleriot; Immanuel Kwok; Xin Chen; Amanda Shin; Weijie Huang; Regine J Dress; Charles-Antoine Dutertre; Andreas Schlitzer; Jinmiao Chen; Lai Guan Ng; Honglin Wang; Zhiduo Liu; Bing Su; Florent Ginhoux
Journal:  Cell       Date:  2019-09-05       Impact factor: 41.582

6.  Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.

Authors:  Edward Hitti; Tatiana Iakovleva; Matthew Brook; Stefanie Deppenmeier; Achim D Gruber; Danuta Radzioch; Andrew R Clark; Perry J Blackshear; Alexey Kotlyarov; Matthias Gaestel
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

7.  The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway.

Authors:  Seth A Brooks; John E Connolly; William F C Rigby
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

8.  Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.

Authors:  Sonika Patial; Alan D Curtis; Wi S Lai; Deborah J Stumpo; Georgette D Hill; Gordon P Flake; Mark D Mannie; Perry J Blackshear
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

9.  uPA Attenuated LPS-induced Inflammatory Osteoclastogenesis through the Plasmin/PAR-1/Ca(2+)/CaMKK/AMPK Axis.

Authors:  Yosuke Kanno; Akira Ishisaki; Eri Kawashita; Hiromi Kuretake; Kanako Ikeda; Osamu Matsuo
Journal:  Int J Biol Sci       Date:  2016-01-01       Impact factor: 6.580

10.  Down-regulation of tristetraprolin expression results in enhanced IL-12 and MIP-2 production and reduced MIP-3alpha synthesis in activated macrophages.

Authors:  Ulla Jalonen; Riina Nieminen; Katriina Vuolteenaho; Hannu Kankaanranta; Eeva Moilanen
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

View more
  5 in total

Review 1.  Functional RNA Dynamics Are Progressively Governed by RNA Destabilization during the Adaptation to Chronic Hypoxia.

Authors:  Rebekka Bauer; Sofie Patrizia Meyer; Karolina Anna Kloss; Vanesa Maria Guerrero Ruiz; Samira Reuscher; You Zhou; Dominik Christian Fuhrmann; Kathi Zarnack; Tobias Schmid; Bernhard Brüne
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

2.  Targeting Zinc Finger Proteins with Exogenous Metals and Molecules: Lessons learned from Tristetraprolin, a CCCH type Zinc Finger.

Authors:  Kiwon Ok; Milos R Filipovic; Sarah L J Michel
Journal:  Eur J Inorg Chem       Date:  2021-07-21       Impact factor: 2.551

3.  A single-cell transcriptional gradient in human cutaneous memory T cells restricts Th17/Tc17 identity.

Authors:  Christopher P Cook; Mark Taylor; Yale Liu; Ralf Schmidt; Andrew Sedgewick; Esther Kim; Ashley Hailer; Jeffrey P North; Paymann Harirchian; Hao Wang; Sakeen W Kashem; Yanhong Shou; Timothy C McCalmont; Stephen C Benz; Jaehyuk Choi; Elizabeth Purdom; Alexander Marson; Silvia B V Ramos; Jeffrey B Cheng; Raymond J Cho
Journal:  Cell Rep Med       Date:  2022-08-16

Review 4.  Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.

Authors:  Chisato Kinoshita; Noriko Kubota; Koji Aoyama
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

Review 5.  Prostanoids and Resolution of Inflammation - Beyond the Lipid-Mediator Class Switch.

Authors:  Tobias Schmid; Bernhard Brüne
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.